Henry Schein Inc HSIC

Morningstar Rating
€1,335.36 +137.07 (11.44%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

HSIC is trading at a 215% premium.
Price
MXN 1,317.47
Fair Value
MXN 7,317.95
Uncertainty
High
1-Star Price
MXN 3,886.17
5-Star Price
MXN 6,354.12
Economic Moat
Yjzct
Capital Allocation

News

Trading Information

Previous Close Price
€1,198.29
Day Range
€1,325.001,325.00
52-Week Range
€1,122.001,325.00
Bid/Ask
€1,321.00 / €1,320.00
Market Cap
€169.20 Bil
Volume/Avg
1 / 1

Key Statistics

Price/Earnings (Normalized)
17.41
Price/Sales
0.80
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
2.54%

Company Profile

Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services primarily to office-based dental and medical practitioners, as well as alternate sites of care. The company operates in two reportable segments; health care distribution and technology & value-added services. The healthcare distribution segment is engaged in combining global dental and medical businesses and distributes consumable products, small equipment, laboratory products, and Vitamins. The technology and value-added services reportable segment provides software, technology & other value-added services to health care practitioners. The majority of revenue is derived from the health care distribution segment.
Sector
Healthcare
Industry
Medical Distribution
Stock Style Box
Small Core
Total Number of Employees
26,000

Comparables

Valuation

Metric
HSIC
AGL
CYH
Price/Earnings (Normalized)
17.41
Price/Book Value
2.841.95
Price/Sales
0.800.260.06
Price/Cash Flow
12.931.20
Price/Earnings
HSIC
AGL
CYH

Financial Strength

Metric
HSIC
AGL
CYH
Quick Ratio
0.671.321.14
Current Ratio
1.551.361.47
Interest Coverage
4.71−32.761.27
Quick Ratio
HSIC
AGL
CYH

Profitability

Metric
HSIC
AGL
CYH
Return on Assets (Normalized)
4.34%−7.62%−0.19%
Return on Equity (Normalized)
12.06%−21.88%
Return on Invested Capital (Normalized)
6.70%−19.92%5.57%
Return on Assets
HSIC
AGL
CYH

Medical Distribution Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
McKesson Corp
MCK
YjfjhpkxCpbcvb$62.9 Bil
Cencora Inc
COR
DzhmgrfxXyjjkb$43.1 Bil
Cardinal Health Inc
CAH
XpczdwwdVvmkcv$27.1 Bil
Shanghai Pharmaceuticals Holding Co Ltd Class H
SHPMF
Gbdtc$10.0 Bil
Shanghai Pharmaceuticals Holding Co Ltd ADR repr Class H
SHPMY
Kyjkdhd$10.0 Bil
Sinopharm Group Co Ltd ADR
SHTDY
Kmgxks$9.1 Bil
Sinopharm Group Co Ltd
SHTDF
Tywntsz$9.1 Bil
Amplifon SpA Az nom Post Frazionamento
AMFPF
Qnttnh$6.4 Bil
Ebos Group Ltd ADR
EBOSY
Dqwvhqd$4.5 Bil
Medipal Holdings Corp ADR
MAHLY
Bbph$3.7 Bil

Sponsor Center